Back
Cytokinetics Quote, Financials, Valuation and Earnings
Sponsored
CYTK
Sponsored
"This Changes Everything" - Trump Hands Millions Massive IRS Gift
Learn More Here
Sell
50
CYTK
Cytokinetics
Last Price:
54.71
Seasonality Move:
9.1%
7 Day Trial
ALL ACCESS PASS
$
7
Trump's IRS Hands Massive 'Victory Gift' To 401K Owners
Shield your IRA, 401(k) and pension savings from this coming anti-Trump backlash.Cytokinetics Price Quote
$54.71
+0.01 (+-2.22%)
(Updated: November 15, 2024 at 2:38 AM ET)
Cytokinetics Key Stats
Sell
50
Cytokinetics (CYTK)
is a Sell
Day range:
$54.56 - $56.31
52-week range:
$30.68 - $110.25
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
1,818.01
P/B ratio:
0%
Volume:
896K
Avg. volume:
1.1M
1-year change:
59.52%
Market cap:
$6.5B
Revenue:
$7.5M
EPS:
$-5.38
How Much Does Cytokinetics Make?
-
How Much Are Cytokinetics's Sales Annually?
CYTK Revenues are $7.5M -
How Much Profit Does Cytokinetics's Make A Year?
CYTK net income is -$526.2M
Is Cytokinetics Growing As A Company?
-
What Is Cytokinetics's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.22% -
What Is Cytokinetics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Cytokinetics Stock Price Performance
-
Did Cytokinetics Stock Go Up Last Month?
Cytokinetics share price went up by 0.37% last month -
Did CYTK's Share Price Rise Over The Last Year?
CYTK share price rose by 59.52% over the past 1 year
What Is Cytokinetics 52-Week High & Low?
-
What Is Cytokinetics’s 52-Week High Share Price?
Cytokinetics has traded as high as $110.25 over the past 52 weeks -
What Is Cytokinetics’s 52-Week Low Share Price?
Cytokinetics has traded as low as $30.68 over the past 52 weeks
Cytokinetics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Cytokinetics?
-
How Much Debt Does Cytokinetics Have?
Total long term debt quarterly is $656M -
How Much Cash Does Cytokinetics Have?
Cash and short term investments quarterly total is $1B -
What Is Cytokinetics’s Book Value Per Share?
Book value per share is -0.12
Is Cytokinetics Cash Flow Positive?
-
What Is CYTK Cash Flow From Operations?
Cash flow from operations (TTM) is -$404.4M -
What Is Cytokinetics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $1.1B -
What Is Cytokinetics’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$745.4M
Cytokinetics Return On Invested Capital
-
Is Management Doing A Good Job?
CYTK return on invested capital is -142.05% -
What Is Cytokinetics Return On Assets?
ROA measures how assets are converting to revenues and is -54.04% -
What Is CYTK Return On Equity?
ROE is a measure of profitability and is 0%
Cytokinetics Earnings Date & Stock Price
-
What Is Cytokinetics's Stock Price Today?
A single share of CYTK can be purchased today for 54.70 -
What Is Cytokinetics’s Stock Symbol?
Cytokinetics trades on the nasdaq under the ticker symbol: CYTK -
When Is Cytokinetics’s Next Earnings Date?
The next quarterly earnings date for Cytokinetics is scheduled on February 27, 2025 -
When Is CYTK's next ex-dividend date?
Cytokinetics's next ex-dividend date is November 15, 2024 -
How To Buy Cytokinetics Stock?
You can buy Cytokinetics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Cytokinetics Competitors
-
Who Are Cytokinetics's Competitors?
Below is a list of companies who compete with Cytokinetics or are related in some way:
Cytokinetics Dividend Yield
-
What Is CYTK Dividend Yield?
Cytokinetics’s dividend yield currently is 0% -
What Is Cytokinetics’s Payout Ratio?
Cytokinetics’s payout ratio is 0% -
When Did Cytokinetics Last Pay A Dividend?
The latest dividend pay date is November 15, 2024 -
What Is Cytokinetics’s Dividend Per Share?
Cytokinetics pays a dividend of $0.00 per share
Cytokinetics Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | -9.26% |
Revenue: | 22.49% | -60.77% |
Analyst Recommendations
Buy Recommendations: | 7 |
---|---|
Hold Recommendations: | 4 |
Sell Recommendations: | 0 |
Price Target: | 81.29 |
Upside from Last Price: | 48.62% |